Alzheimer's Disease and Related DementiaDERANCT07545577
Randomized Controlld Trial of Dementia Education Resources for Action
A study testing DERA Online Training Program in people with Alzheimer's Disease and Related Dementia, run by George Mason University at 1 site in United States.
Trial summary
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Alzheimer's Disease and Related Dementia
- What is being tested?
- DERA Online Training Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Jun 2026to 31 Aug 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age 18 years or older
- Currently working as a community health worker or serving in a community health worker-related role
- Able to read and understand English
- Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys
- Willing and able to provide informed consent
Who cannot join
- Previously completed the DERA training program
- Unable to complete study procedures in English
- Unable to access the online training platform or study surveys
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Online
Fairfax, Virginia, 22030
Alicia Hong, 703-993-1929, yhong22@gmu.edu
yhong22@gmu.edu
About this study
Official title: Evaluation of Dementia Education and Resources for Action
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
- Conditions
- Alzheimer's Disease and Related Dementia
- Being tested
- DERA Online Training Program
- Keywords
- Community Health Workers, ADRD, Self-efficacy, Stigma, Digital Health Intervention
- Medical subject headings
- Alzheimer Disease, Social Stigma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DERA Online Training ProgramBehavioural
The Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement.
| Study group | Role | What they receive |
|---|---|---|
| Immediate DERA Intervention | Experimental | Participants assigned to this arm will receive immediate access to the DERA online training program. The program is web-based platform and includes 7 structured modules on dementia knowledge, stigma reduction, and the role of community health workers in supporting individuals with dementia and their caregivers. Receives: Behavioral: DERA Online Training Program |
| Waitlist Control | No intervention | Participants assigned to this arm will not receive access to the DERA program during the study period. They will complete baseline and post-intervention assessments over a similar timeframe as the intervention group. After completion of the post-intervention assessment, participants will be provided access to the DERA training program. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dementia Knowledge
Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS). The DKAS is a validated instrument that measures knowledge across multiple domains, including causes, symptoms, risk factors, and care considerations. DKAS-25 total score ranges from 0 to 50. Items are scored 0-2, with higher scores indicating greater dementia-related knowledge.
Measured: Baseline to post-intervention (approximately 6-8 weeks)
Secondary outcomes (2)
Dementia-Related Stigma
Dementia-related stigma will be assessed using an adapted 8-item stigma scale with response options ranging from strongly disagree to strongly agree. Total scores range from 8 to 40, with higher scores indicating greater dementia-related stigma.
Measured: Baseline to post-intervention (approximately 6-8 weeks)
Self-Efficacy in Dementia Care
Self-efficacy will be measured using a study-specific Community Health Worker Dementia Role Self-Efficacy Scale assessing confidence in performing dementia-related tasks, including education, communication, support, and service navigation. Response options range from "Not at all confident" to "Extremely confident." Total scores range from 8 to 40, with higher scores indicating greater self-efficacy in dementia-related service delivery.
Measured: Baseline to post-intervention (approximately 6-8 weeks)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Apr 2026
- Study start16 Jun 2026
- Primary completion30 Dec 2026 (estimated)
- Study completion31 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alzheimer's Disease and Related DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- George Mason University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Y. Alicia Hong, George Mason University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07545577
- Sponsor's protocol ID
- STUDY00000621
- Acronym
- DERA
- Status last verified
- May 2026
- First submitted
- 16 Apr 2026
- Last updated
- 11 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be publicly shared due to privacy considerations. De-identified data may be made available upon reasonable request to the study investigators, subject to institutional review and data use agreements.
Study at a glance
From the registry record, last updated by the sponsor on 11 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Dementia Education and Resources for Action
- ClinicalTrials.gov ID
- NCT07545577
- Acronym / sponsor ID
- DERA / STUDY00000621
- Conditions
- Alzheimer's Disease and Related Dementia
- Keywords
- Community Health Workers, ADRD, Self-efficacy, Stigma, Digital Health Intervention
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- George Mason UniversityUniversity, hospital or other
- Study start
- 16 Jun 2026 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 31 Aug 2027 (estimated)
- First posted
- 22 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Immediate DERA Intervention | Experimental | Behavioral: DERA Online Training ProgramParticipants assigned to this arm will receive immediate access to the DERA online training program. The program is web-based platform and includes 7 structured modules on dementia knowledge, stigma reduction, and the role of community health workers in supporting individuals with dementia and their caregivers. |
| Waitlist Control | No intervention | –Participants assigned to this arm will not receive access to the DERA program during the study period. They will complete baseline and post-intervention assessments over a similar timeframe as the intervention group. After completion of the post-intervention assessment, participants will be provided access to the DERA training program. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Age 18 years or older
- Currently working as a community health worker or serving in a community health worker-related role
- Able to read and understand English
- Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys
- Willing and able to provide informed consent
Key exclusion criteria (3 listed)
- Previously completed the DERA training program
- Unable to complete study procedures in English
- Unable to access the online training platform or study surveys
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DERA Online Training ProgramThe Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement. | Behavioural | Immediate DERA Intervention |
Primary outcome
Dementia Knowledge
Time frame: Baseline to post-intervention (approximately 6-8 weeks)
Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS). The DKAS is a validated instrument that measures knowledge across multiple domains, including causes, symptoms, risk factors, and care considerations. DKAS-25 total score ranges from 0 to 50. Items are scored 0-2, with higher scores indicating greater dementia-related knowledge.
2 secondary outcomes
Dementia-Related Stigma
Time frame: Baseline to post-intervention (approximately 6-8 weeks)
Self-Efficacy in Dementia Care
Time frame: Baseline to post-intervention (approximately 6-8 weeks)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Sep 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be publicly shared due to privacy considerations. De-identified data may be made available upon reasonable request to the study investigators, subject to institutional review and data use agreements.
Related trials for Alzheimer's Disease and Related Dementia
Active, not recruitingPhase 2
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
Alzheimer's Disease
RecruitingPhase 3
Nabilone for Agitation Blinded Intervention Trial
Alzheimer Disease, Agitation
Active, not recruitingPhase 2
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
Arterial Stiffness, White Matter Lesions
Not yet recruiting
Music Listening for Chronic Pain in Adults With Early-Stage Dementia
Chronic Pain, Alzheimer Disease
Not yet recruiting
A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement
Memory Disorders, Mild Cognitive Impairment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing DERA Online Training Program in people with Alzheimer's Disease and Related Dementia, run by George Mason University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Alicia Hong (7039931929, yhong22@gmu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dementia Knowledge (time frame: Baseline to post-intervention (approximately 6-8 weeks)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.